Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HBB | P68871 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29101971 | 0.98 | TAAR1 (0.45) | TAAR1LMNAPOLBMAPTTDP1 | |
| SCHEMBL1523197 | 0.76 | — | — | |
| SCHEMBL1533571 | 0.76 | — | — | |
| SCHEMBL3605224 | 0.76 | — | — | |
| SCHEMBL9669161 | 0.76 | — | — | |
| SCHEMBL4263926 | 0.76 | — | — | |
| SCHEMBL2059056 | 0.76 | — | — | |
| SCHEMBL4299008 | 0.76 | — | — | |
| SCHEMBL755097 | 0.76 | — | — | |
| SCHEMBL9044558 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 544 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4308181-B1 | SUTURES | UNIV BELFAST (GB) | 2025-11-19 | — | — | EP | claimed |
| CN-119978317-A | Epoxy resin intrinsic flame retardant material cured by phosphorus-containing imidazole curing agent and preparation method thereof | 广东精英高新材料股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-114395390-B | Fluorescence array sensor based on aggregation-induced emission type metal organic framework, and preparation method and application thereof | 南京理工大学 | 2023-12-15 | — | — | CN | claimed |
| CN-111039977-B | Phosphorylylation reagent and application thereof in oligonucleotide synthesis | 广州同隽医药科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114395390-A | Fluorescence array sensor based on aggregation-induced emission type metal organic framework and preparation method and application thereof | 南京理工大学 | 2022-04-26 | — | — | CN | claimed |
| CN-109796411-B | Method for preparing 4, 5-dinitroimidazole by using microchannel reactor | 南京理工大学 | 2022-01-14 | — | — | CN | claimed |
| CN-107365439-B | Novel chloroprene rubber vulcanization method | 华南理工大学 | 2020-02-18 | — | — | CN | claimed |
| CN-102574250-A | Soldering process using electrodeposited indium and/or gallium, and article comprising an intermediate layer with indium and/or gallium | ASTRON ADVANCED MATERIALS LTD | 2012-07-11 | — | — | CN | claimed |
| US-4300962-A | Ammonium nitrate explosive systems | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1981-11-17 | — | — | US | claimed |
| JP-63310873-A | — | — | None | — | — | JP | disclosed |
| US-12637415-B2 | Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for intravenous administration and the use thereof | DRACEN PHARMACEUTICALS, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12616679-B2 | Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereof | DRACEN PHARMACEUTICALS, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12605472-B2 | Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof | ACTINIUM PHARMACEUTICALS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4089823-B1 | SEPARATOR, ELECTRICAL APPARATUS CONTAINING SUCH SEPARATOR, AND PREPARATION METHOD THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD (HK) | 2026-04-01 | — | — | EP | disclosed |
| US-5256792-A | Explosives and gun propellants; thermally stable, insensitive to shock | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1993-10-26 | — | — | US | disclosed |
| EP-0290991-B1 | PROCESS FOR THE PRODUCTION OF PYRAZOLES | BASF Aktiengesellschaft (DE) | 1992-07-29 | — | — | EP | disclosed |
| JP-S63310873-A | 4,5-DINITROIMIDAZOLE DERIVATIVE | TAIHO YAKUHIN KOGYO KK | 1988-12-19 | — | — | JP | disclosed |
| EP-0290991-A1 | Process for the production of pyrazoles | BASF Aktiengesellschaft (DE) | 1988-11-17 | — | — | EP | disclosed |
| US-4430445-A | POLYAMIDINE HOHO- AND COPOLYMERS; OXIDATION RESISTANCE; METAL EXTRACTION; POLYEPOXIDE CURING AGENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-02-07 | — | — | US | disclosed |
| US-4300962-A | Ammonium nitrate explosive systems | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1981-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616679-B2 | Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereof | GLUL, QPCT, QPCTL | TAAR1 4604/4885LMNA 3930/4885POLB 557/4885 |
| US-12605472-B2 | Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof | HBZ, CD47, HBB | TAAR1 4350/4885LMNA 2908/4885POLB 636/4885 |
| US-12637415-B2 | Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for intravenous administration and the use thereof | GLS, GLUL, GLS2 | TAAR1 4542/4885LMNA 3864/4885POLB 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.